Tag: Pharmacology Achievement Award

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Published on by World Science Awards

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Professor in Community Medicine, University of Sri Jayewardenepura, Sri Lanka

Professor Christine Sampatha Evangeline Goonewardena is an accomplished academic and medical professional specializing in Community Medicine. With a career spanning over three decades, she has made substantial contributions to public health, particularly in maternal and child health, reproductive health, and public health education. As a professor at the University of Sri Jayewardenepura in Sri Lanka, she has led numerous research projects that have influenced health policies and improved community-level healthcare practices. Her work has garnered several national and international awards, underscoring her impact in public health. In addition to her research, she has held leadership positions and contributed to academic development through teaching and mentoring young researchers. Her publications, both individually and in collaboration, have addressed critical public health challenges and brought her widespread recognition in Sri Lanka and beyond. Professor Goonewardena’s dedication to improving healthcare outcomes reflects her commitment to academic excellence and community well-being.

Profile:

Scopus Profile

Education

Professor Goonewardena has an extensive educational background in medicine and public health. She earned her MBBS from North Colombo Medical College in Sri Lanka in 1990, laying the foundation for her medical career. She later pursued an MSc in Community Medicine from the Post Graduate Institute of Medicine, University of Colombo, in 1994, which included in-depth research on breastfeeding practices in urban slums. Her commitment to advancing community health led her to complete her MD in Community Medicine from the same institution in 2001, with a thesis focused on intrapartum and postpartum care in primary care settings. In 2003, she further specialized by obtaining a Diploma in Reproductive Health from the Liverpool School of Tropical Medicine, UK. This diverse academic background, combining clinical and public health expertise, has equipped her to address key health issues at both national and international levels.

Professional Experience

Professor Goonewardena has held various pivotal roles throughout her career in academia and public health. Currently, she serves as a Professor of Community Medicine at the Faculty of Medical Sciences, University of Sri Jayewardenepura, a position she has held since 2017. Before this, she served as a Senior Lecturer in the same department from 2002 to 2017, demonstrating her deep commitment to teaching and research. She also led the Department of Community Medicine as Head from 2006 to 2009 and again from 2012 to 2014. Earlier in her career, she worked as a Medical Officer specializing in Maternal and Child Health in the Colombo Municipality from 1991 to 1996. Her extensive work experience includes both clinical practice and academic roles, allowing her to bridge the gap between research and practical health solutions. She also serves as a Specialist Community Physician in the University Field Health Area.

Research Interests

Professor Goonewardena’s research interests primarily focus on maternal and child health, reproductive health, adolescent health, and health system improvements in low-resource settings. She has a particular interest in exploring ways to improve healthcare delivery at the community level, especially in underprivileged and rural areas. Her work has frequently addressed issues such as postpartum care, antenatal care, menstrual hygiene, and breastfeeding practices, aiming to provide evidence-based solutions to improve public health outcomes. In recent years, she has expanded her research to include mental health and cancer pain management, reflecting a holistic approach to healthcare that considers both physical and mental well-being. Her research is not only academically rigorous but also highly practical, often leading to recommendations that influence health policy and clinical practice in Sri Lanka.

Award and Recognition

Professor Goonewardena has been the recipient of numerous prestigious awards for her contributions to public health and research. In 2002, she received the Sir Nicholas Attygalle Award for her research on improving intrapartum and postpartum care. She has also been recognized with multiple Best Paper and Best Oral Presentation awards at national and international conferences, including the South Asian Association of Physiologists and the Sri Lanka Medical Association. In 2015, she won the Best Poster Award at the International Research Conference of Sir John Kotelawala Defence University for her work on antenatal care knowledge. Her achievements reflect both the depth and breadth of her research, with accolades in areas ranging from adolescent health to cancer pain management. These awards underscore her role as a leading researcher in community medicine, both within Sri Lanka and internationally.

 

Publication Top Notes

  • Delay among women reporting symptoms of breast cancer
    📝 Authors: Kumari PBV, Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Cancer: A hidden burden (Editorial)
    📝 Author: Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Extra-Curricular Activities and Factors Associated Among School-Going Adolescents in an Urban Area of Sri Lanka
    📝 Authors: Weerasinghe IE, Gunawardana CSE, Jayatilake JAMS
    📅 Year: 2014
    📚 Citation: Global Education Review, Vol 2, No 2, February 2014, 72-82
  • Vaginal discharge: Women’s health-seeking behavior and cultural practices
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Perera PPR, Fernandopulle RC
    📅 Year: 2015
    📚 Citation: International Journal of Current Research, Vol 7, Issue 6, June 2015
  • Quality of life of caregivers and impact on the nuclear family of children with leukaemia in the National Cancer Institute of Sri Lanka
    📝 Authors: Pathirana TI, Goonewardena CSE, Wijesiriwardane I
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E18, 1-5
  • Factors associated with growth faltering in Sri Lankan infants: A case-control study in selected child welfare clinics in Sri Lanka
    📝 Authors: Nevinda de Silva, Wijerathna K, Kahatapitiya S, Silva P, Perera R, Goonewardena S
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E19, 1-9
  • Public Health Midwives’ role in health education regarding vaginal discharge: A Cross-Sectional Descriptive Study
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Fernandopulle RC, Perera PPR
    📅 Year: 2016
    📚 Citation: International Journal of Scientific Research and Management, Vol 4, Issue 06, 4303-4310
  • Pre-hospital care received by injured children less than five years admitted to the Lady Ridgeway Hospital for children, Colombo
    📝 Authors: Gunawardhana YAGK, Goonewardena CSE
    📅 Year: 2015
    📚 Citation: Journal of the College of Community Physicians of Sri Lanka, Vol 21, No 1
  • Self-medication practices and misuse of medicine among mothers of young children attending a teaching hospital in Sri Lanka
    📝 Authors: De Silva BP, Hussain FH, Ginige G, Kulathunge A, Kannangara H, Goonawardane S, Gamage M
    📅 Year: 2017
    📚 Citation: Sri Lanka Journal of Child Health, 46
  • Assessment of knowledge on the disease, its complications, and management strategies among hypertensive patients attending medical clinics at Teaching Hospital, Batticaloa, Sri Lanka
    📝 Authors: Kisokanth G, Illankoon IMPS, Arulanandem K, Goonewardena CSE, Sundaresan KT, Joseph J
    📅 Year: 2016
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 3: E30, 1-1

Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Published on by World Science Awards

Assoc Prof Dr. Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Assoc Prof Dr. Chun Liu, Jinan University, China

Chun Liu is a distinguished researcher in Earth and Planetary Sciences, recognized for her significant contributions to the understanding of planetary geology and geophysics. Currently pursuing her PhD at [insert university name], her research focuses on [insert specific research area or project]. Píng has authored several influential papers published in top-tier journals, highlighting her innovative methodologies and insights into planetary processes. With a strong commitment to advancing scientific knowledge, she actively engages in community outreach and mentorship programs, inspiring the next generation of Earth scientists. Her dedication and impactful research have earned her the prestigious Best Scholar Award.

Profile:

 

Education

Chun Liu holds a Doctoral Degree in Environmental Science and Engineering from Hunan University, where she conducted her research at the State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, under the supervision of Prof. Zhongwu Li. She completed her doctoral studies in June 2019. Chun also served as a visiting scholar at the University of California, Merced, from November 2017 to December 2018, collaborating with Prof. Asmeret Asefaw Berhe. Prior to her doctorate, she earned a Master’s Degree in Hydrology and Water Resources Science from Hunan Normal University, working under the guidance of Profs. Dianqing Lv and Hongsong Chen. Chun began her academic journey with a Bachelor’s Degree in Water Resources and Hydroelectric Engineering from Hunan Agricultural University, mentored by Prof. Bangsong Yao. Her diverse educational background has equipped her with a strong foundation in environmental science and water resource management.

Professional Experience

Chun Liu is currently an Associate Professor at the Institute of Groundwater and Earth Sciences at Jinan University in Guangzhou, Guangdong, China, a position she has held since September 2019. In this role, she focuses on advancing research in groundwater management and environmental science, contributing to both academic knowledge and practical applications in the field. Her expertise and dedication to teaching have made her a valuable asset to the institute, where she engages in mentoring students and collaborating on interdisciplinary research projects aimed at addressing critical environmental challenges.

Research Interests

Chun Liu’s research interests encompass a diverse range of topics within environmental science, with a particular focus on soil erosion and carbon cycling. She investigates soil biogeochemistry and karst hydrology, exploring the complex interactions between these systems and climate change. Additionally, Chun is dedicated to studying groundwater pollution and prevention strategies. Her work involves applying various tracers, such as isotopes, spectroscopy, and biomarkers, to identify eroded organic matter, as well as utilizing models to quantify this eroded material. Through her research, she aims to enhance understanding of these critical processes and develop effective solutions for environmental management.

Award and Recognition

Chun Liu has received numerous honors and awards throughout her academic career, underscoring her exceptional contributions to the field of environmental science. In 2018, she was recognized with an ESI Hot Paper distinction, placing her in the top 1% for agricultural science, as well as achieving a Highly Cited Paper status. Additionally, her master’s thesis was awarded Excellent Master’s Thesis in Hunan Province in 2017. Chun was also honored as an Excellent Doctoral Candidate and Excellent Doctoral Graduate at Hunan University in 2018. Earlier in her career, she was recognized as an Advanced Individual in a university program aimed at enhancing social practice activities among officials in 2012. These accolades reflect her dedication to research and academic excellence.

 

Publication Top Notes

Liu, C., Wang, D., Dong, F. F., Hu, B. X., Li, Z. W., Huang, B. (2021). Modeling organic matter sources of sediment fluxes in eroding landscapes: Review, key challenges, and new perspectives. Geoderma, 383, 114704.

Lan, G. Y., Liu, C., Wang, H., Cao, J. H., Tang, W., Li, Q., Hu, B. X. (2021). Linking soil redistribution to soil organic carbon using 210Pb ex along different complex toposequences in a karst region, southwest China. Catena, 202, 105239.

Wang, D., Huang, X. D., Qiao, N., Geng, Q. L., Liu, Y. Z., Song, H. Q., Yang, Z. L., Liu, C.* (2020). Effects of mowing and fertilization on soil quality in a semiarid grassland of North China. Land Degradation & Development, 32, 1656-1666.

Liu, C., Li, Z. W.*, Berhe, A. A., Hu, B. X. (2020). The isotopes and biomarker approaches for identifying eroded organic matter sources in sediments: A review. Advances in Agronomy, 162, 257-303.

Liu, C., Li, Z. W.*, Hu, B. X., Yan, J., Xiao, H. B. (2020). Identifying eroded organic matter sources in sediments at a fluvial system using multiple tracers on the Loess Plateau of China. Catena, 193, 104623.

Li, Z. W., Peng, H., Xie, B. G., Liu, C., Nie, X. D., Wang, D. Y., Huang, M., Xiao, H. B., Shi, L., Zhang, X. Q., Jiang, J. Y. (2020). Dissolved organic matter in surface runoff in the Loess Plateau of China: the role of rainfall events and land-use. Hydrological Processes, 34, 1446-1459.

Liu, C., Li, Z. W.*, Berhe, A. A., Zeng, G. M., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H. (2019). Chemical characterization and source identification of organic matter in eroded sediments: role of land use and erosion intensity. Chemical Geology, 506, 97-112.

Liu, C., Li, Z. W.*, Berhe, A. A., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H., Zeng, G. M. (2019). Characterizing eroded dissolved organic matter in a loess hilly catchment using fluorescence EEM-PARAFAC and UV-Visible absorption: Insights from source identification and carbon cycling. Geoderma, 334, 37-48. (ESI 1% Highly Cited Paper).

Liu, C., Li, Z. W., Chang, X. F., He, J. J., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Soil carbon and nitrogen sources and redistribution as affected by erosion and deposition processes: A case study in a loess hilly-gully catchment, China. Agriculture, Ecosystems & Environment, 253, 11-22.

Liu, C., Li, Z. W.*, Chang, X. F., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Apportioning source of erosion-induced organic matter in the hilly-gully region of the Loess Plateau in China: Insight from lipid biomarker and isotopic signature analysis. Science of the Total Environment, 621, 1310-1319.

Farouk Oladoja | Pharmacology | Best Researcher Award

Published on by World Science Awards

Dr. Farouk Oladoja | Pharmacology | Best Researcher Award

Lecturer, Olabisi Onabanjo University , Nigeria

Dr. Farouk Adedeji Oladoja is a Lecturer II at Olabisi Onabanjo University’s Department of Pharmacology and Toxicology. He holds a B.Pharm from Olabisi Onabanjo University and an M.Sc in Pharmacology, Therapeutics, and Toxicology from the University of Lagos. He is currently pursuing a PhD in Pharmacology. Dr. Oladoja’s research focuses on pharmacological activities of natural compounds, including antidiabetic and antioxidant properties, and toxicological studies. He has worked on various projects such as the effects of Datura stramonium and the evaluation of SARS-CoV-2 variants. Dr. Oladoja has co-authored multiple peer-reviewed articles and contributed to the understanding of alternative medicine and phytomedicine in Africa. His professional experience includes teaching pharmacology to medical, pharmacy, and nursing students. His excellence has been recognized through awards, including the 2021 first prize for poster presentation at the University of Lagos. Dr. Oladoja continues to contribute significantly to pharmacology research and education.

Profile:

Education

Dr. Farouk Adedeji Oladoja is an accomplished scholar with a strong educational background in Pharmacology and related fields. He earned his Bachelor of Pharmacy (B.Pharm Hons) from Olabisi Onabanjo University, Ago-Iwoye, in 2014. Driven by his passion for advanced knowledge, he pursued a Master of Science (M.Sc) in Pharmacology, Therapeutics, and Toxicology at the University of Lagos, Akoka, completing the program in 2019. In addition to his pharmaceutical education, Dr. Oladoja has diversified his skill set by obtaining professional certifications. He became an Associate of the Institute of Chartered Accountants of Nigeria (ICAN) in 2018, enhancing his expertise in financial management. He also holds memberships in the Chartered Institute of Materials and Warehousing Management (ACIWM) and the Chartered Institute of Supply Chain Management (ACISM), further broadening his interdisciplinary knowledge. Currently, Dr. Oladoja is awaiting admission for his PhD in Pharmacology at the University of Lagos, Nigeria.

Professional Experience

Dr. Farouk Adedeji Oladoja has a solid foundation in Pharmacology and Toxicology, having served as a Lecturer at Olabisi Onabanjo University (OOU) since January 2021. With over two years of teaching experience, he has been actively involved in instructing undergraduate students in pharmacology across various programs, including Medicine, Nursing, and Pharmacy. His previous roles span clinical and community pharmacy positions, notably at HealthPlus Pharmacy, Olabisi Onabanjo University Teaching Hospital, and Mapic Pharmacy. In his current role, Dr. Oladoja teaches core pharmacology courses, supervises undergraduate projects, and contributes to curriculum development. His research interests include antidiabetic, antioxidant, and neuropharmacological studies, with a particular focus on African phytomedicine. He has authored numerous peer-reviewed papers and collaborated on projects ranging from toxicology studies to the phylogenetic analysis of SARS-CoV-2 variants in Nigeria. Dr. Oladoja’s academic and research contributions reflect his dedication to advancing pharmacological knowledge and practice.

Research Skills

Dr. Oladoja Farouk Adedeji possesses extensive research skills, particularly in pharmacology, toxicology, and natural products. His research expertise spans drug discovery, pharmacokinetics, pharmacodynamics, and the therapeutic properties of medicinal plants. Dr. Oladoja has conducted in-depth studies on the antidiabetic, antioxidant, and neuropharmacological properties of various plant extracts, contributing to scientific knowledge on alternative medicine and toxicology. His work also extends to toxicological assessments, having investigated the acute and sub-acute toxicity of herbal extracts. He is skilled in data collection, manuscript writing, and experimental design, as demonstrated in his numerous publications on plant-based treatments and toxicology. His involvement in advanced biochemical analysis, including antioxidant and anti-inflammatory assays, underscores his proficiency in laboratory techniques and research methodologies. Dr. Oladoja is committed to exploring the pharmacological potential of natural compounds, contributing significantly to the fields of pharmacology and toxicology.

Award and Recognition

Dr. Farouk Adedeji Oladoja has demonstrated excellence in pharmacology and toxicology, earning multiple awards and recognition throughout his career. Notably, he received the prestigious Distinguished Merit Award for Excellent Achievement in Sagamu for his contributions to community development. His academic prowess was acknowledged during his time at Olabisi Onabanjo University, where he was honored with the PANS OOU Excellence Award for being the Most Distinguished Student in 2013 and again in 2014. In 2021, Dr. Oladoja secured first place at the Annual General Meeting and Scientific Conference of the University of Lagos’ Faculty of Basic Medical Sciences for his outstanding poster presentation. These accolades reflect his dedication to research, education, and service, marking him as a leader in his field. His commitment to advancing pharmacology through research and teaching has earned him a well-deserved reputation for academic and professional excellence.

Conclusion

Dr. Oladoja has made significant contributions to the fields of pharmacology and toxicology within his short academic career. His innovative research, collaborative publications, and commitment to advancing African phytomedicine make him a strong contender for the Best Researcher Award. However, addressing his career advancement and seeking external funding would further solidify his position as an academic leader.

Publication Top Notes

  1. Title: Citrus aurantifolia (Chrism.) Swingle peel extract attenuate nephrotoxicity induced by doxorubicin
    Authors: Oyinloye, E.O.; Murtala, A.A.; Oladoja, F.A.; Kasumu, O.E.; Osipitan, L.E.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 11, Article ID: 100412
  2. Title: Cajanus cajan (L) Millsp seeds extract prevents rotenone-induced motor- and non-motor features of Parkinson disease in mice: Insight into mechanisms of neuroprotection
    Authors: Olubodun-Obadun, T.G.; Ishola, I.O.; Folarin, O.R.; Olopade, J.O.; Adeyemi, O.O.
    Year: 2024
    Journal: Journal of Ethnopharmacology
    Volume: 322, Article ID: 117623
  3. Title: Bambusa vulgaris attenuates Haloperidol-induced motor deficit and non-Motor co-morbidity in rats through up-regulation of Dopamine transmission and mitigation of pro-inflammatory cytokines activities
    Authors: Murtala, A.A.; Oladapo, O.E.; Oladoja, F.A.; Olaniran, E.O.; Osonuga, O.O.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100375
  4. Title: Hypoglycemic, antidiabetic and toxicological evaluation of leaf extract of Xylopia parviflora (A. rich.) Benth
    Authors: Oladoja, F.A.; Irokosu, E.S.; Oyinloye, E.O.; Pender, G.C.; Popoola, O.A.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100358
  5. Title: Evaluation of Phytochemical constituents, Total Phenolic contents and in vitro Antioxidant Activities of Mucuna pruriens fractions leaves
    Authors: Elijah, O.O.; Murtala, A.A.; Oladoja, F.A.; Aderinola, A.A.; Kasumu, E.O.
    Year: 2023
    Journal: Journal of Phytomedicine and Therapeutics
    Volume: 22(1), pp. 1017–1034
  6. Title: Effects of glyphosate-based herbicide on gametes fertilization and four developmental stages in Clarias gariepinus
    Authors: Kale, O.E.; Adebesin, A.N.; Kale, T.F.; Wahab, M.; Ebele, C.C.
    Year: 2023
    Journal: Heliyon
    Volume: 9(4), e15048
  7. Title: Ethyl acetate fraction of Mucuna pruriens leaves mitigates diclofenac-induced hepatotoxicity via modulation of biochemical and histological parameters changes in Wistar Rats
    Authors: Oyinloye, O.; Murtala, A.; Oladoja, F.; Kasumu, E.; Iloka, P.
    Year: 2023
    Journal: Pharmacia
    Volume: 70(4), pp. 1201–1208
  8. Title: Alternative Medicine in Health Care: Is the Time not Now to Standardize African Phytomedicine to Indigenize Health Care and Create Entrepreneurial Opportunities?
    Authors: Adedeji, A.A.; Talabi, I.E.; Oladoja, F.
    Year: 2023
    Book: Medical Entrepreneurship: Trends and Prospects in the Digital Age, pp. 259–273
  9. Title: Antibiotic utilization study in a teaching hospital in Nigeria
    Authors: Sekoni, K.F.; Oreagba, I.A.; Oladoja, F.A.
    Year: 2022
    Journal: JAC-Antimicrobial Resistance
    Volume: 4(5), dlac093
  10. Title: Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity
    Authors: Akanji, M.A.; Elijah, O.O.; Oyedolapo, A.A.; Olatundun, S.O.; Edatomolaosi, O.L.
    Year: 2022
    Journal: Drug Metabolism and Personalized Therapy
    Volume: 37(3), pp. 305–314

 

Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Published on by World Science Awards

Assist Prof Dr. Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assistant Professor, EDA, Egypt

With a solid foundation in pharmacy, including a Bachelor’s, Master’s, and PhD from Cairo University, and a position as Associate Professor, this individual demonstrates exceptional expertise. Their diverse professional experience spans quality control, management, and academic roles, showcasing their leadership and practical knowledge in the pharmaceutical field. Their prolific research output includes numerous publications on advanced drug delivery systems and nanotechnology, reflecting significant contributions to pharmaceutical sciences. Active participation in various training courses, workshops, and international conferences highlights their commitment to continuous professional development. Additionally, their multilingual skills enhance their ability to collaborate in diverse settings. Overall, their comprehensive background in education, research, and professional development, combined with their active engagement in the scientific community, makes them a highly suitable candidate for the Best Researcher Award.

Education

The candidate has a robust educational background that serves as the foundation of their expertise in the field of pharmaceutical sciences. They earned a Bachelor of Pharmacy degree from Cairo University in 1996, graduating with honors, which set the stage for their academic and professional journey. Their pursuit of advanced knowledge led them to complete a Master’s degree in Pharmaceutics in 2007 and later a PhD in 2011, both from the same esteemed institution. This rigorous academic training has equipped them with in-depth knowledge of pharmaceutics, drug formulation, and pharmaceutical analysis. In 2019, they further solidified their academic credentials by attaining the position of Associate Professor, demonstrating their commitment to education, research, and mentorship. Their continuous academic progression reflects a strong commitment to excellence and a desire to contribute significantly to the pharmaceutical sciences, positioning them as a thought leader in their field and a prime candidate for the Best Researcher Award.

Profesional Experience

The candidate has an extensive professional background in the pharmaceutical sector, beginning their career as a QC analyst for raw materials at NODCAR from 1996 to 1999. They then transitioned to academia as a teaching assistant at the Faculty of Pharmacy, October University, in 1999. Between 2000 and 2012, they worked as a QC analyst specializing in physical properties before moving into management roles, including quality manager and deputy lab manager. From 2016 to 2021, they served as a technical manager, demonstrating their expertise in overseeing laboratory operations and maintaining quality standards. Their role expanded further as they joined several committees, contributing to updating pharmaceutical guidelines and developing the Egyptian pharmacopeia. In 2021, they became the lab manager of the physicochemical lab at the Egyptian Drug Authority (EDA), where they continue to lead and innovate in quality control and research.

Research Skill

The candidate possesses exceptional research skills, demonstrated through a prolific publication record in high-impact journals and extensive experience in developing innovative pharmaceutical formulations. They have expertise in designing and conducting complex experimental studies, including the use of advanced methodologies like Box–Behnken design for optimization and in vivo evaluations. Their research work spans various domains, including nanotechnology, ocular drug delivery, and gastroretentive systems, showcasing versatility and a strong ability to adapt to emerging scientific trends. Additionally, their role in supervising master’s and PhD theses highlights their leadership in guiding future researchers. The candidate is also well-versed in utilizing statistical analysis tools and quality-by-design approaches, which are critical for ensuring the rigor and reliability of research findings. Their ability to translate research into practical applications, coupled with active participation in committees that shape pharmaceutical guidelines, underscores a profound impact on both academic and industry standards in the pharmaceutical sciences.

Awards And Recoginition

The individual has received multiple accolades throughout their career, reflecting their outstanding contributions to the field of pharmaceutical sciences. Their expertise in pharmaceutics and dedication to research have been recognized by esteemed institutions and professional bodies. Notably, they have been honored for their innovative work in drug delivery systems and quality management, which have had a significant impact on the pharmaceutical industry. They have been a valuable member of committees responsible for updating pharmaceutical guidelines and establishing national standards, further highlighting their influence and leadership in the field. Additionally, their research publications in renowned international journals have been widely cited, earning them recognition among peers as a leading researcher. Their participation in prestigious conferences and workshops, both as a presenter and a participant, underscores their commitment to continuous learning and sharing knowledge. These recognitions affirm their position as a distinguished professional dedicated to advancing pharmaceutical science and improving healthcare outcomes.

Conclution

The individual’s blend of academic excellence, practical experience, prolific research output, and continuous professional growth makes them a highly suitable candidate for the Best Researcher Award. Their achievements reflect their dedication to advancing pharmaceutical science and their impact on the field.

Publication Top Notes

  1. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
    • Authors: Nagham H. Kamal, Fatema R. Saber, Abeer Salama, Dalia M. N. Abouhussein, Soha Ismail, Hala M. El-Hefnawy, Meselhy R. Meselhy
    • Year: 2024
    • Citation: Kamal NH, Saber FR, Salama A, Abouhussein DMN, Ismail S, El-Hefnawy HM, Meselhy MR. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency. Future Journal of Pharmaceutical Sciences. 2024 Aug 19. doi:10.1186/s43094-024-00678-2.
  2. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
    • Authors: Abeer Khattab, Soha Ismail, Areeg M. Abd-Elrazek
    • Year: 2024
    • Citation: Khattab A, Ismail S, Abd-Elrazek AM. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment. AAPS PharmSciTech. 2024 Jun 27. doi:10.1208/s12249-024-02852-4.
  3. Optimization of topical curcumin spanlastics for melanoma treatment
    • Authors: Soha Ismail, Doaa Garhy, Howida K. Ibrahim
    • Year: 2023
    • Citation: Ismail S, Garhy D, Ibrahim HK. Optimization of topical curcumin spanlastics for melanoma treatment. Pharmaceutical Development and Technology. 2023 May 28. doi:10.1080/10837450.2023.2204926.
  4. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
    • Authors: Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary, Amany H. El-Shazly
    • Year: 2022
    • Citation: Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation. Journal of Liposome Research. 2022 Oct 2. doi:10.1080/08982104.2022.2025828.
  5. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
    • Authors: Marwa Farrag Abd El-Aziz, Soha Ismail, Mina Ibrahim Tadros, Mohamed Ahmed Elnabarawi
    • Year: 2020
    • Citation: Abd El-Aziz MF, Ismail S, Tadros MI, Elnabarawi MA. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI. Pharmaceutical Development and Technology. 2020 May 27. doi:10.1080/10837450.2020.1720235.
  6. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
    • Authors: Marwa H. Shukr, Soha Ismail, Samya Mahmoud Ahmed
    • Year: 2019
    • Citation: Shukr MH, Ismail S, Ahmed SM. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity. Journal of Drug Delivery Science and Technology. 2019 Feb. doi:10.1016/j.jddst.2018.12.001.
  7. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
    • Authors: Dalia S. Shaker, Soha Ismail, Selwan Hamed, Eman M. El-Shishtawy
    • Year: 2018
    • Citation: Shaker DS, Ismail S, Hamed S, El-Shishtawy EM. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy. Journal of Drug Delivery Science and Technology. 2018 Dec. doi:10.1016/j.jddst.2018.09

 

Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Published on by World Science Awards

 Dr. Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Dr. Alaa Alsalloum, Novosibirsk State University, Russia.

Dr. Alaa Alsalloum is a dedicated researcher in the fields of immunology and microbiology, known for her contributions to understanding immune responses and microbial interactions. With a strong commitment to excellence in research, she focuses on innovative approaches to tackle infectious diseases and enhance immunological health. Alaa’s work is characterized by a collaborative spirit and a passion for advancing scientific knowledge, making her a valuable asset in the pursuit of breakthroughs in health and disease management.

Profile:

Education

Alaa Alsalloum’s educational journey began at the National Center for Distinguished in Syria, where she completed high school from October 2011 to June 2014. She then earned her Bachelor of Science in Pharmacy from the University of Damascus, focusing on Biomedical Sciences, with a thesis titled “Phage Nanobody Immuno-PCR for Ultra-sensitive Detection of Growth Hormone (GH).” Following this, Alaa participated in a general education program at Kazan (Volga Region) Federal University to master professional educational programs in Russian from October 2018 to June 2019. She continued her studies at Kazan Federal University, where she completed her master’s degree in the Institute of Medicine and Biology, focusing on the earlier immune markers of multiple sclerosis in an animal model for her thesis. Currently, Alaa is pursuing her PhD at Novosibirsk State University, specializing in molecular immunology, with her research centered on the phenotypic and functional characteristics of T-lymphocytes with genetically modified antigen-recognizing receptors specific to solid tumor antigens.

 Interests

Alaa Alsalloum is committed to community service, having volunteered with the Association for Persons with Special Needs (APSN) in Deir Atiyah, Syria, from July 2014 to September 2015. During her time there, she contributed to supporting individuals with special needs, helping to enhance their quality of life and promote inclusivity. This experience reflects her dedication to making a positive impact in the lives of others and highlights her passion for service beyond her academic pursuits.

 Skills

Alaa Alsalloum possesses a robust set of technical skills acquired through her research in immunology and molecular biology during her Bachelor’s and Master’s theses. She is proficient in DNA and RNA extraction, PCR, electrophoresis, bacterial transformation, ELISA tests, immunochemistry, NanoString technology, and cell culture techniques. Additionally, she has experience with PBMC isolation, viral transduction of T-lymphocytes, dendritic cell differentiation protocols, tetramer assays, cell sorting protocols, flow cytometry, and intracellular flow cytometry staining. Alaa also has foundational knowledge in RT-PCR, cell analysis, Seahorse technology, 3D cell culture, and single-cell sequencing.On the interpersonal side, she has developed strong presentation and communication skills through participation in various seminars focused on communication and leadership. Alaa is adept at collaborating within a team while also demonstrating the ability to work independently, making her a well-rounded candidate in both research and professional settings.

 

Publication Top Notes

Alsalloum, A. (2024). NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy. Clinical and Translational Medicine. DOI: 10.1002/ctm2.70020. ISSN: 2001-1326.

Alsalloum, A. (2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), Article 2805. DOI: 10.3390/biomedicines11102805.

Alsalloum, A. (2023). Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. International Journal of Molecular Sciences, 24(20), Article 15134. DOI: 10.3390/ijms242015134.

Alsalloum, A. (2023). Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow. PLOS ONE, 18(6), Article e0287793. DOI: 10.1371/journal.pone.0287793. ISSN: 1932-6203.

Alsalloum, A. (2023). The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers, 15(6), Article 1779. DOI: 10.3390/cancers15061779.

Alsalloum, A. (2022). Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1. Immunologiya, 43(5), 536-547. DOI: 10.33029/0206-4952-2022-43-5-536-547.

Alsalloum, A. (2022). Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro. Immunologiya, 43(4), 401-411. DOI: 10.33029/0206-4952-2022-43-4-401-411.

Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Published on by World Science Awards

Assoc Prof Dr. Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

2004, EDA, Egypt

Dr. Omar Abdel-Hamed Ahmed-Farid is a highly qualified candidate for the Research for Best Researcher Award. With a robust academic and professional background, Dr. Farid has significantly impacted the field of physiology and analytical chemistry. His impressive citation metrics—1889 citations, an H-index of 24, and an I10-index of 61—highlight his influential research. As the Unit Administration Manager at the Egyptian Drug Authority, he excels in regulatory compliance, quality assurance, and team leadership. His previous roles include Technical Manager and Drug Quality Control Specialist, where he managed laboratory practices and ensured adherence to international standards. Dr. Farid’s contributions to policy development and staff training further demonstrate his dedication to advancing industry standards and professional excellence. His extensive research experience, combined with his leadership in regulatory and quality assurance roles, makes him a strong contender for this award.

Profile:

Education

Dr. Omar Abdel-Hamed Ahmed-Farid has a distinguished educational trajectory that underscores his expertise in physiology and analytical chemistry. He began his academic journey as an Assistant Researcher in Physiology in 2005, gradually advancing through roles as an Assistant Researcher, Researcher, and ultimately becoming an Associate Professor of Physiology in 2020. His progression reflects a deepening of knowledge and a growing commitment to the field. Dr. Farid’s education has been marked by hands-on experience and rigorous training in high-performance analytical techniques, such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC). This solid educational foundation has been instrumental in his success in research, quality assurance, and regulatory compliance within the pharmaceutical and medical diagnostics sectors. His academic background is a testament to his dedication to advancing scientific knowledge and improving industry standards

Professional Experience

Dr. Omar Abdel-Hamed Ahmed-Farid’s professional experience showcases a profound impact on the fields of physiology and analytical chemistry. As the Unit Administration Manager of Diagnostic Kits and Medical Supplies at the Egyptian Drug Authority (EDA), he oversees regulatory compliance, quality assurance, and documentation, ensuring adherence to national and international standards. His previous role as Technical Manager involved the implementation and maintenance of ISO-17025 and GLP standards, critical for maintaining laboratory accuracy and reliability. Dr. Farid’s extensive experience also includes managing laboratory equipment procurement and validation, as well as training staff on analytical techniques and quality protocols. His contributions to policy development and regulatory practices highlight his leadership and commitment to advancing industry standards. His career trajectory, from Drug Quality Control Specialist to Associate Professor, reflects a deep and evolving expertise, underpinned by a dedication to both scientific excellence and professional development.

Research Skill

Dr. Omar Abdel-Hamed Ahmed-Farid possesses a robust set of research skills, underscored by his extensive experience and academic background. His proficiency in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Spectrophotometry highlights his capability to conduct precise and comprehensive biochemical analyses. Dr. Farid has demonstrated expertise in determining neurotransmitters, amino acids, and cellular metabolites, utilizing advanced methods like Atomic Absorption Spectroscopy and ELISA techniques. His research includes investigating enzymatic and non-enzymatic antioxidants, analyzing tissue samples using the Comet Assay, and studying animal blood pressure. His ability to apply complex analytical methods and maintain high standards in research protocols is further evidenced by his contributions to method validation and compliance with international standards. Dr. Farid’s analytical skills, combined with his commitment to quality and innovation, underscore his exceptional research capabilities.

Award and Recognition

Dr. Omar Abdel-Hamed Ahmed-Farid has demonstrated exceptional expertise and dedication in the field of physiology and analytical chemistry, earning widespread recognition for his impactful research and professional contributions. With 1889 citations, an H-index of 24, and a Researchgate score of 46.42, his scholarly work has significantly influenced the scientific community. As the Unit Administration Manager at the Egyptian Drug Authority, Dr. Farid has excelled in ensuring regulatory compliance, maintaining high-quality standards, and leading a team dedicated to advancing diagnostic practices. His commitment to policy development, training, and innovation underscores his role as a pivotal figure in the industry. Dr. Farid’s achievements reflect a remarkable blend of academic excellence and practical impact, making him a distinguished candidate for the Research for Best Researcher Award.

Conclusion

Dr. Omar Abdel-Hamed Ahmed-Farid’s comprehensive research contributions, extensive professional experience, and leadership in regulatory and quality assurance roles make him a highly suitable candidate for the Research for Best Researcher Award. His impact on the field through his research, coupled with his commitment to advancing regulatory practices and training, aligns well with the criteria for this prestigious award.

Publication Top Notes

  • Publication Title: Recombinant Interleukin − 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of Schistosoma mansoni-Infected Mice
    • Authors: Mehran, H.S., Nady, S., Kassab, R.B., Ahmed-Farid, O.A., El-Hennamy, R.E.
    • Journal: Journal of Neuroimmune Pharmacology
    • Year: 2024
    • Volume: 19
    • Issue: 1
    • Pages: 37
    • Citations: 0
  • Publication Title: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway
    • Authors: El-Marasy, S.A., AbouSamra, M.M., Moustafa, P.E., Galal, A.F., Farouk, H., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 13559
    • Citations: 0
  • Publication Title: The study of wound healing activity of Thespesia populnea L. bark, an approach for accelerating healing through nanoparticles and isolation of main active constituents
    • Authors: Abdel Halim, M.B., Eid, H.H., El Deeb, K.S., Ahmed-Farid, O.A., El Messiry, H.M.
    • Journal: BMC Complementary Medicine and Therapies
    • Year: 2024
    • Volume: 24
    • Issue: 1
    • Article Number: 85
    • Citations: 0
  • Publication Title: Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood–testis barrier remodeling
    • Authors: Saleh, D.O., Baraka, S.M., Jaleel, G.A.A., Hassan, A., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 1910
    • Citations: 1
  • Publication Title: Gastro-Protective, Antioxidant, and Anti-Inflammatory Potential of Three Vegetable Oils Against Indomethacin-Induced Gastric Ulceration in Rats: in Vivo and in Vitro Study
    • Authors: Mohamed, M.M., Ahmed-Farid, O.A.
    • Journal: Egyptian Journal of Chemistry
    • Year: 2024
    • Volume: 67
    • Issue: 7
    • Pages: 341–359
    • Citations: 0
  • Publication Title: A combined administration of GABA agonist and L-histidine synergistically alleviates obesity-induced neuro-lipotoxicity and distorted metabolic transcriptome
    • Authors: Al-Malki, E.S., Ahmed-Farid, O.A., Moustafa, M.M.A., Linhardt, R.J., Warda, M.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02177
    • Citations: 0
  • Publication Title: Tolerability of Artemisia absinthium in anorexia: Targeting of neuronal appetite and satiety in zinc deficiency diet rat model
    • Authors: El-bakry, K.A.-E.K.M., Bahnasawy, M.H., Deef, L.E., Ahmed-Farid, O.A.-H., El-Naeli, S.S.B.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02162
    • Citations: 0
  • Publication Title: Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats
    • Authors: Attia, F.M., Kassab, R.B., Ahmed-Farid, O.A., Abdel Moneim, A.E., El-Yamany, N.A.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume: (in press)
    • Citations: 0
  • Publication Title: Neurological study on the effect of CeNPs and/or La Cl3 on adult male albino rats
    • Authors: Abdel-Rahman, M., Elmasry, H.M., Ahmed-Farid, O.A., Hegazy, S.M., Rezk, M.M.
    • Journal: Journal of Trace Elements in Medicine and Biology
    • Year: 2024
    • Volume: 81
    • Article Number: 127323
    • Citations: 2
  • Publication Title: Nanoliposomal amino acids counteracting protein malnutrition induced hematopoietic and hepatic complications
    • Authors: Ahmed, R.F., Elbaset, M.A., Farouk, H., Ahmed-Farid, O.A.H., Nasr, M.
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2023
    • Volume: 89
    • Article Number: 105051
    • Citations: 0

 

Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Published on by World Science Awards

Dr. Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Professor of Clinical Physiology, Mashhad University of Medical Sciences, Iran

Dr. Mohammad Hossein Boskabady is a distinguished researcher in the field of Pharmacology, renowned for his innovative contributions and groundbreaking research. With a strong background in pharmacological sciences, Dr. Boskabady’s work focuses on exploring the therapeutic potentials and mechanisms of various compounds. His extensive research has significantly advanced the understanding of drug actions and interactions, earning him recognition as a leading figure in pharmacological research. Dr. Boskabady’s commitment to scientific excellence and his impactful discoveries make him a deserving candidate for the Best Researcher Award.

Profile

Education 

Dr. Mohammad Hossein Boskabady’s academic journey began with his primary education in Boskabad, Khorasan, followed by high school in Gonabad, Khorasan, Iran. He earned his M.D. from Mashhad University of Medical Sciences. Dr. Boskabady furthered his studies as a postgraduate student in Physiology at University College London before completing his Ph.D. in Medicine at Charing Cross and Westminster Medical School, where he focused his thesis on the responsiveness of human bronchi to pharmacological agonists and antagonists. With a strong commitment to advancing pharmacological research, Dr. Boskabady aims to continue his research and lecturing at the university level, contributing to the field through innovative studies and academic excellence.

Employment

Dr. Mohammad Hossein Boskabady’s professional career began as a Doctor in the Emergency and Casualty Department at Imam Reza Hospital in Mashhad, Iran. Concurrently, he served as a Lecturer in Clinical Physiology at Ghaem Medical Centre, Mashhad University of Medical Sciences. Over the years, Dr. Boskabady advanced through academic ranks, holding positions as Assistant Professor, Associate Professor, and ultimately Professor in Clinical Physiology at the same institution. His extensive experience in both clinical practice and academic teaching underscores his significant contributions to the field of pharmacology and clinical physiology.

Awards

Dr. Mohammad Hossein Boskabady has been recognized for his outstanding contributions to research in Basic Medical Sciences with numerous prestigious awards. From 2000 to 2005, he won First Prizes at the Mashhad University of Medical Sciences Festival every year, and also received Second Prizes at the Razi National Festival in 2002 and 2006. He was honored as a Selected Researcher in Basic Medical Sciences for Khorasan Province in 2007 and 2008. Dr. Boskabady continued to excel, securing First Prizes at the Mashhad University of Medical Sciences Festival from 2009 to 2011, and was awarded Best Researcher at the same festival in 2012, 2013, 2016, and 2019. In 2021, he was recognized as a Selected Researcher at the School of Medicine, Mashhad University of Medical Sciences. Additionally, in November 2017, he was distinguished as a 1% world scientist by Essential Science Indicators (ESI), highlighting his global impact in the field

Official Posts

Dr. Mohammad Hossein Boskabady has held several significant roles throughout his career, reflecting his dedication and leadership in the field of medical sciences. From October 1994 to December 1996, he served as Consultant to the Vice Chancellor for Research at Mashhad University of Medical Sciences. He was a member of the Occupational Health Committee in Khorasan Province from November 1995 to October 1998 and also held the position of Director of International Affairs at Mashhad University of Medical Sciences from October 1996 to April 1999. Additionally, Dr. Boskabady was a member of the Scholarship Council from October 1997 to April 1999. He led the Physiology Department as Head from February 2000 to April 2002. Dr. Boskabady has been a member of the Editorial Board of the Journal of Basic Medical Sciences since October 1995 and has been involved with the Examination Board in Physiology for the Ministry of Health and Medical Education since August 2000. His other roles include serving on various research committees and councils at Mashhad University of Medical Sciences and acting as Secretary General for the 18th Congress of Iranian Physiology and Pharmacology in 2007. Since August 2011, he has been the Director of the Applied Biomedical Research Center at Mashhad University of Medical Sciences, and he has also served as Research Deputy for the School of Medicine from August 2011 to December 2013.

Publication Top Notes
  • Boskabady, M. H., & Snashall, P. D. (1992). Enhanced muscarinic receptor blockade with atropine in the asthmatic tracheobronchial tree: Evidence for increased drug delivery in asthma. American Review of Respiratory Disease, 145(5), 756-761. DOI: 10.1164/ajrccm/145.5.756.
  • Boskabady, M. H., & Snashall, P. D. (1996). Short term variation of atropine blockade in the tracheobronchial tree of asthmatic subjects. Medical Journal of the Islamic Republic of Iran, 10(3), 183-189. DOI: 10.17102/mjiri.1996.0108.
  • Boskabady, M. H., & Snashall, P. D. (1997). Enhanced histamine H1 receptor blockade with chlorpheniramine in the asthmatic tracheobronchial tree: Further evidence for increased drug delivery in asthma. Medical Journal of the Islamic Republic of Iran, 11(2), 115-122. DOI: 10.17102/mjiri.1997.0063.
  • Boskabady, M. H., & Shhabi, M. (1997). Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Iranian Journal of Medical Sciences, 22(4), 127-133. DOI: 10.30476/ijms.1997.0549.
  • Boskabady, M. H., Rakhshandah, H., & Moetamedshariati, V. (1998). Bronchodilatory and anticholinergic effects of Carum copticum on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 11(5), 329-334. DOI: 10.17102/mjiri.1998.0134.
  • Boskabady, M. H., & Harati, M. (1998). Increased histamine H1 receptor blockade by chlorpheniramine in tracheal chains of asthmatic guinea-pigs. Medical Journal of the Islamic Republic of Iran, 12(2), 265-271. DOI: 10.17102/mjiri.1998.0089.
  • Boskabady, M. H., & Talebi, M. (1999). Bronchodilatory and anticholinergic effects of Carum carvi on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 12(3), 345-351. DOI: 10.17102/mjiri.1999.0154.
  • Boskabady, M. H., & Adel-Kardan, S. (1999). Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea-pigs. Pharmacology, 58(6), 300-308. DOI: 10.1159/000029652.
  • Boskabady, M. H., & Shikhi, J. (2000). Inhibitory effect of Carum copticum on histamine (H1) receptors of isolated guinea pig tracheal chains. Journal of Ethnopharmacology, 69(2), 217-227. DOI: 10.1016/S0378-8741(99)00244-3.
  • Boskabady, M. H., & Simaei, N. (1999). Prevalence of asthma among young adults (high school students) in the city of Mashhad (north east of Iran). Iranian Journal of Medical Sciences, 24(1), 48-52. DOI: 10.30476/ijms.1999.0442.
  • Boskabady, M. H., & Snashall, P. D. (2000). Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta blockade in asthma. Respirology, 5(2), 111-118. DOI: 10.1046/j.1440-1843.2000.00243.x.
  • Boskabady, M. H., & Moemeni, A. (2000). Stimulatory effect of Carum copticum on beta2 adrenoceptors of isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 13(3), 273-278. DOI: 10.17102/mjiri.2000.0192.
  • Boskabady, M. H., Karbandy, S., & Abedinzadah, A. (2000). The effects of arterial O2 saturation and heart rate on blood pressure. Medical Journal of the Islamic Republic of Iran, 14(2), 37-41. DOI: 10.17102/mjiri.2000.0200.
  • Boskabady, M. H., & Karimian, M. (2000). Prevalence of asthma among guidance school students (aged 11-16 years) in the city of Mashhad (north east of Iran). Archives of Iranian Medicine, 3(3), 165-169. DOI: 10.30476/aim.2000.0109.
  • Boskabady, M. H., & Hosaini, M. (2000). Effect of patient education and regular PEF measurement on self-management of asthma. Iranian Journal of Allergy, Asthma, and Immunology, 1(2), 159-164. DOI: 10.30476/ijaai.2000.0111.
  • Boskabady, M. H., & Ramazani, M. (2001). Relaxant effect of Pimpinella anisum on isolated guinea pig tracheal chains and its possible mechanism(s). Journal of Ethnopharmacology, 74(1), 83-88. DOI: 10.1016/S0378-8741(00)00382-5.
  • Boskabady, M. H., Keshmiri, M., Banihashemi, B., & Anvary, K. H. (2002). Lung function values in healthy non-smoking urban adults in Iran. Respiration, 69(4), 320-326. DOI: 10.1159/000065155.
  • Boskabady, M. H., & Klahdoz, G. H. (2002). Prevalence of asthma symptoms among the adult population in the city of Mashhad (north-east of Iran). Respirology, 7(3), 267-272. DOI: 10.1046/j.1440-1843.2002.00413.x.
  • Boskabady, M. H., & Shirmohammadi, B. (2002). Effect of Nigella sativa on isolated guinea pig trachea. Archives of Iranian Medicine, 5(2), 103-107. DOI: 10.30476/aim.2002.0145.
  • Boskabady, M. H., & Shiravi, N. (2002). Inhibitory effect of Nigella sativa on histamine (H1) receptors of isolated guinea pig tracheal chains. Pharmaceutical Biology, 40(8), 596-602. DOI: 10.1076/1388-0209(200208)4008-0005.

Dr. David Haefliger | Pharmacology | Best Researcher Award

Published on by World Science Awards

Dr. David Haefliger | Pharmacology | Best Researcher Award

Dr. David Haefliger, CHUV, Switzerland

Dr. David Haefliger is a distinguished expert in pharmacology, recognized for his groundbreaking research and contributions to the field. With a strong background in drug interactions and therapeutic efficacy, Dr. Haefliger’s work has significantly advanced the understanding of pharmacological mechanisms and their clinical applications. His research is widely published in leading journals and has been instrumental in shaping contemporary practices in pharmacology. As a recipient of the Best Researcher Award, Dr. Haefliger continues to drive innovation and excellence in his field, demonstrating an unwavering commitment to advancing medical science and improving patient outcomes.

Profile

Scoopus

Education 

Dr. David Haefliger has an extensive educational and professional background in the medical field. He earned his Bachelor’s degree in Medicine in June 2012 and his Master’s degree in Medicine in June 2015, both from the University of Lausanne, Switzerland. In addition to his foundational degrees, he completed the Swiss Board Examination in General Internal Medicine in June 2019, and he is an Advanced Cardiovascular Life Support Provider, certified in October 2016. Most recently, in 2024, Dr. Haefliger obtained a Certificate of Advanced Studies in Clinical Research from the University of Lausanne, further solidifying his expertise and commitment to advancing clinical research.

Proffesional Experience

Since February 2022, Dr. David Haefliger has been working in the Service of Clinical Pharmacology at the Department of Medicine, University Hospital Lausanne, Switzerland. Prior to this role, he served in the Service of Infectious Diseases at the University Hospital Lausanne from November 2019 to October 2021. Dr. Haefliger also gained valuable experience in the Intensive Care Unit at Fribourg Hospital from November 2018 to October 2019. His career began in Internal Medicine at Fribourg Hospital, where he worked from November 2015 to October 2018.

 

Publication Top Notes

  • Haefliger D, Chehade H, Livio F, Rodrigues-Veiga V, Diezi L, Marzolini C. Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report. Semin Dial. 2024.
  • Dao K, Buettcher M, Golhen K, et al. Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use. J Clin Pharmacol. 2024.
  • Dao K, Shechtman S, Weber-Schoendorfer C, et al. Use of GLP-1 Receptor Agonists in Early Pregnancy and Reproductive Safety: A Multicentre, Observational, Prospective Cohort Study Based on the Databases of Six Teratology Information Services. BMJ Open. 2024.
  • Grütter S, Haefliger D, Wuerzner G, Yerly P, Bouchardy J, Rutz T. The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient. CJC Pediatr Congenit Heart Dis. 2023.
  • Haefliger D, Marzolini C, Lamoth F, Pabst T, Buclin T, Livio F. Clinically Relevant Bidirectional Drug-Drug Interaction Between Midostaurin and Voriconazole. Br J Clin Pharmacol. 2023.
  • Haefliger D, Livio F. Pharmacothérapie – Nouveaux Médicaments et Vaccins Disponibles en 2022 [Pharmacotherapy: New Drugs and Vaccines in 2022]. Rev Med Suisse. 2023.
  • Desgranges F, Tadini E, Munting A, et al. Post-COVID-19 Syndrome in Outpatients: A Cohort Study. J Gen Intern Med. 2022.
  • Regina J, Papadimitriou-Olivgeris M, Burger R, et al. Epidemiology, Risk Factors, and Clinical Course of SARS-CoV-2 Infected Patients in a Swiss University Hospital: An Observational Retrospective Study. PLoS One. 2020.
  • Grandjean T, Haefliger D, Arroyo D, Cook S. Coronary Sinus Reduction for the Treatment of Refractory Angina. Cardiovasc Med. 2018.
  • Haefliger D, Chuard C. Légionellose [Legionellosis]. Rev Med Suisse. 2017.

Articles with Acknowledgments (as a member of the RegCOVID Study Group):

  • Galperine T, Choi Y, Pagani JL, et al. Temporal Changes in Fecal Microbiota of Patients Infected with COVID-19: A Longitudinal Cohort. BMC Infect Dis. 2023.
  • COVID-19 Host Genetics Initiative. Mapping the Human Genetic Architecture of COVID-19. Nature. 2021.
  • Bibert S, Guex N, Lourenco J, et al. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol. 2021.

Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Published on by World Science Awards

Dr. Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Assistant Director , Baba Farid University of Health Sciences , India .

Dr. Vikas Gupta is a distinguished pharmaceutical scientist specializing in pharmacognosy and herbal drugs. With over a decade of experience in academia and research, he has made significant contributions to the field of pharmaceutical sciences, particularly in the development and quality control of herbal medicines. His career is marked by a strong academic background, diverse professional roles, innovative research, and numerous awards recognizing his excellence in the field.

Profile
Education

Dr. Gupta holds a Ph.D. in Pharmaceutical Sciences from Baba Farid University of Health Sciences, Faridkot, earned in January 2019. He completed his M. Pharmacy in Pharmacognosy from Punjabi University, Patiala, in 2008 with first-class honors, and his B. Pharmacy from Akal College of Pharmacy & Technical Education, Mastuana Sahib (Sangrur), under Punjab Technical University in 2005, also with first-class honors. His strong academic foundation is further reinforced by his high school education, where he achieved first-class marks from Spring Dales Public School, Sangrur.

Professional Experience

Currently, Dr. Vikas Gupta serves as the Assistant Director and Associate Professor at the University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, and the University Institute of Pharmaceutical Sciences and Research, Faridkot. His professional journey has included roles as a Production Supervisor at G. M. Remedies Pvt. Ltd., Lecturer at S. D. College of Pharmacy, and Senior Research Fellow at the National Institute of Ayurvedic Pharmaceutical Research. His progression through these roles demonstrates his ability to lead, teach, and conduct advanced research in pharmaceutical sciences.

 

Research Interests

Dr. Gupta’s primary research interests lie in the field of pharmacognosy, with a particular focus on herbal drugs, quality control, and chromatography. He is passionate about exploring the therapeutic potential of natural products and has dedicated his research to developing and validating herbal medicines that can meet modern healthcare standards. His work is driven by a commitment to improving the safety, efficacy, and quality of herbal drugs, ensuring they are a viable option in the pharmaceutical industry.

Research Skills

Dr. Gupta possesses a wide range of research skills, particularly in the areas of herbal drug technology and chromatography. His expertise includes the development and quality control of herbal drugs, where he employs advanced chromatographic techniques to ensure the purity and potency of these natural medicines. His technical skills are complemented by his experience in supervising and mentoring students in research, where he guides them through complex scientific inquiries and projects.

Awards and Recognition

Dr. Vikas Gupta’s contributions to pharmaceutical sciences have been widely recognized. He has received numerous awards, including the prestigious “Research Excellence Award-2022” from INSC International Publishers and the “Innovative Research Award” for his work on economic plant-based anti-anxiety drugs. He has also been honored with fellowships from the UPYA Foundation of Multidisciplinary Sciences, the Indian Association of Pharmaceutical Scientists and Technologists, and the Scholars Academic and Scientific Society. His recognition extends internationally, with awards such as the Bentham Ambassador by Bentham Science Publishers and the Bharat Gaurav Puraskar for his contributions to the field.

Conclusion

Dr. Vikas Gupta’s qualifications, extensive experience, and numerous recognitions make him a compelling candidate for the Scientific Excellence Achievement Award. His contributions to pharmacognosy, herbal drugs, and pharmaceutical sciences are significant and align well with the criteria for such an award.

Publications Top Notes

    1. 2024:
      • Topic: “Recommendations of Apex Health Bodies Remain Localized: Not in Conformity with International Implementation Policy for Urological Disorders”
      • Journal: The Lancet Regional Health – Southeast Asia
    2. 2024:
      • Topic: “Populations Using Traditional Home Remedy at Low Risk for COVID-19 Infection”
      • Journal: Current Traditional Medicine
    3. 2023:
      • Topic: “Future and Research Opportunity in Pharmaceutical Development and Quality Measures”
      • Book Chapter: Pharmaceuticals in Aquatic Environments: Remediation Technologies and Future Challenges
    4. 2023:
      • Topic: “Functional Finishing of Textile Materials Using Silver-Based Functionalized Nanoparticles: Health Perspectives”
      • Book Chapter: Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials: Design, Applications, and Devices
    5. 2023:
      • Topic: “Bioinformatics Paradigms in Drug Discovery and Drug Development”
      • Journal: Current Topics in Medicinal Chemistry
    6. 2022:
      • Topic: “Grain Weight Predictors in Wheat and the Prospects of Their Utilization in Different Production Environments”
      • Journal: Cereal Research Communications
    7. 2022:
      • Topic: “Fast Track Development of Fisetin and Naringenin Based Economic Anti-Anxiety Drug Using Docking Tools”
      • Journal: Asian Journal of Psychiatry
    8. 2022:
      • Topic: “Ashtawarga: The Wonder Medicinal Herbs of Nature”
      • Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods
    9. 2022:
      • Topic: “Future Prospective of Nutraceutical and Functional Food with Herbs and Spices”
      • Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods
    10. 2022:
      • Topic: “Preface”
      • Editorial: New Horizons in Wheat and Barley Research: Global Trends, Breeding and Quality Enhancement

JianYu Chen | Pharmacology | Best Researcher Award

Published on by World Science Awards

Dr. JianYu Chen | Pharmacology | Best Researcher Award

Assistant Professor at Fujian University of Traditional Chinese Medicine, China.

Dr. JianYu Chen is an Associate Professor at Fujian University of Traditional Chinese Medicine, specializing in Pharmacodynamics and the mechanism of active components of Chinese medicine. She holds a Ph.D. in Chinese Medicine from Macao University of Science and Technology and has over five years of experience in academia. Dr. Chen’s research focuses on the treatment of autoimmune and inflammatory diseases using traditional Chinese medicine, with a particular emphasis on targeted inhibition of immune-inflammatory pathways and activation of antioxidant pathways for therapeutic purposes. She has received prestigious awards, including the Macao Special Administrative Region Graduate Science and Technology Research Award, and has published extensively in high-impact journals. Dr. Chen is committed to advancing the understanding and application of traditional Chinese medicine in modern healthcare.

Professional Profiles:

Education

Dr. JianYu Chen pursued her educational journey with a Bachelor’s degree in Chinese Pharmacy from Hubei University of Traditional Chinese Medicine (2007-2011). Building upon this foundation, she obtained a Master’s degree in Chinese Pharmacy from Fujian University of Chinese Medicine (2011-2014). Driven by a passion for research and academia, she further advanced her studies, earning a Doctoral degree in Chinese Medicine from Macao University of Science and Technology (2014-2018). Throughout her academic endeavors, Dr. Chen demonstrated a keen interest in pharmacodynamics and the mechanism of active components of Chinese medicine. Her educational path laid the groundwork for her impactful contributions to the field of traditional Chinese medicine.

Professional Experience

Dr. JianYu Chen has amassed valuable professional experience in the realm of academia and research. Commencing her career as a Lecturer at Fujian University of Chinese Medicine in September 2018, she contributed significantly to the academic environment. In December 2023, she elevated to the position of Associate Professor at the same institution, further solidifying her role in academia. Dr. Chen’s professional journey underscores her commitment to advancing knowledge and research in pharmacology, particularly in the domain of autoimmune and inflammatory diseases.

Research Interest

Dr. JianYu Chen’s research interests are primarily focused on pharmacodynamics and the mechanism of active components found in traditional Chinese medicine (TCM). She is particularly interested in exploring the effects and mechanisms of TCM active components in treating autoimmune and inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, and liver fibrosis. Her research endeavors aim to uncover novel therapeutic strategies derived from TCM that can effectively combat these debilitating conditions.

Award and Honors

Dr. JianYu Chen has garnered prestigious awards and honors in acknowledgment of her remarkable contributions to pharmacology and traditional Chinese medicine. Notably, she was awarded the Macao Special Administrative Region Graduate Science and Technology Research Award in 2018 for her groundbreaking research on active components from herbs against rheumatoid arthritis. This accolade, bestowed by the Macao SAR government, recognizes doctoral students who have significantly advanced knowledge in their field. Additionally, Dr. Chen received the Shanghai Plant Association Outstanding Paper Award in 2014 for her research on TCM active components against hypertrophic scars. These honors underscore Dr. Chen’s dedication to scientific inquiry and her innovative approach to addressing healthcare challenges through pharmacological research.

Research Skills

Dr. JianYu Chen possesses a diverse set of research skills honed through her extensive academic and professional experience in pharmacology and traditional Chinese medicine. Her expertise encompasses pharmacodynamics and the mechanisms of active components of Chinese medicine, with a focus on autoimmune and inflammatory diseases. Dr. Chen has demonstrated proficiency in experimental design, data analysis, and interpretation, enabling her to conduct impactful research in her field. She is adept at conducting literature reviews, experimental protocols, and statistical analyses to generate robust scientific evidence. Additionally, Dr. Chen has a strong background in molecular biology, cell culture techniques, and animal models, facilitating her investigations into the therapeutic potential of traditional Chinese medicine compounds. Her research skills enable her to contribute valuable insights to the understanding and treatment of inflammatory conditions, furthering advancements in pharmacology and healthcare.

Publications

  1. The function of sphingolipids in different pathogenesis of Alzheimer’s disease: A comprehensive review
    • Authors: Wang, X., Li, H., Sheng, Y., Qin, L., Meng, X.
    • Year: 2024
    • Citations: 2
  2. Network pharmacology-based study on mechanism of Zhi-Huang-Zhi-Tong powder in rheumatoid arthritis treatment 
    • Authors: Tian, X.-Y., Yang, Y.-J., Zheng, W.-T., Nan, L.-H., Chen, J.-Y.
    • Year: 2024
    • Citations: 0
  3. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
    • Authors: Wilson, G., Yang, L., Su, X., Chen, J., Ma, X.
    • Year: 2023
    • Citations: 0
  4. Corrigendum to “7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signaling” [Int. Immunopharmacol. 107 (2022) 108557] (International Immunopharmacology (2022) 107, (S1567576922000418), (10.1016/j.intimp.2022.108557))
    • Authors: Chen, J., Zhu, G., Sun, Y., Ma, X., Zheng, Y.
    • Year: 2023
    • Citations: 0
  5. Corrigendum to “7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signalling” [Int. Immunopharmacol. 107 (2022) 108557] (International Immunopharmacology (2022) 112, (S1567576922006646), (10.1016/j.intimp.2022.109180))
    • Authors: Chen, J., Zhu, G., Sun, Y., Ma, X., Zheng, Y.
    • Year: 2023
    • Citations: 0
  6. Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells
    • Authors: Chen, J.-Y., Tian, X.-Y., Wei, S.-S., Ma, X.-Q., Huang, M.-Q.
    • Year: 2023
    • Citations: 2
  7. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3
    • Authors: Chen, L.-L., Xia, L.-Y., Zhang, J.-P., Guo, C., Xu, W.-H.
    • Year: 2023
    • Citations: 3
  8. Neobaicalein Inhibits Th17 Cell Differentiation Resulting in Recovery of Th17/Treg Ratio through Blocking STAT3 Signaling Activation
    • Authors: Chen, J.-Y., Yang, Y.-J., Ma, X.-Q., Zheng, Y.-F., Huang, M.-Q.
    • Year: 2023
    • Citations: 1
  9. Serum and brain metabolomic study reveals the protective effects of Bai-Mi-Decoction on rats with ischemic stroke
    • Authors: Yang, L., Su, X., Lu, F., Chen, J., Ma, X.
    • Year: 2022
    • Citations: 3
  10. Integration of pharmacodynamics and metabolomics reveals the therapeutic effects of 6-acetylacteoside on ovariectomy-induced osteoporosis mice
  • Authors: Liu, J., Ding, S., Yang, L., Chen, J., Ma, X.
  • Year: 2022
  • Citations: 3